From October 1988 to March 2000, 58 @entity1 underwent orthotopic heart transplantation (HTX). Data of 220 heart recipients with the follow up > or = 3 months after HTX were analyzed using the average values of blood pressure measured with the sphigmo-manometer. 65% of @entity1 were diagnosed with the @entity101 ( @entity15773 ). 39.9% of those @entity1 (NTA group) had the systolic blood pressure < or = 140 mmHg and diastolic blood pressure < or = 90 mmHg during pharmacotherapy. 60.1% of @entity101 @entity1 (NTB group) had the systolic pressure > 140 mmHg and/or diastolic pressure > 90 mmHg despite pharmacotherapy. 35% of all @entity1 had normal blood pressure after HTX (HNA group). @entity1 with @entity101 were older and the end stage @entity296 was more frequently indication for HTX. Significantly more females were in NTA group. We observed no influence of the daily dose of @entity205 or other immunosuppressive drugs on @entity15773 . The average blood concentration of @entity205 and @entity618 was similar in all groups. The @entity460 channel blockers and inhibitors of angiotensin converting enzyme were main tool of pharmacotherapy used. In NTA group @entity460 channels blockers were used more frequently. In NTB group there was a statistically significant higher blood level of @entity1011 . After HTX there is a high risk of @entity15773 , which: increases with age, with the @entity296 as indication to HTX, is significantly higher in males, there is no correlation between @entity15773 and the dosage and blood level of @entity205 , increases with @entity177 . In monotherapy @entity460 channel blockers seem to be especially effective.

[Risk of XXXX after heart transplantation in the follow-up period].

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity296 :: ('MESH:D009202', 'Disease') :: ['ischemic cardiomyopathy'] @entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension', 'hypertensive'] @entity15773 :: ('MESH:C537629', 'Disease') :: ['HA'] @entity177 :: ('MESH:D051437', 'Disease') :: ['kidney insufficiency'] @entity205 :: ('MESH:D016572', 'Chemical') :: ['cyclosporine A', 'cyclosporine'] @entity618 :: ('MESH:C063008', 'Chemical') :: ['mycophenolate mofetil'] @entity460 :: ('MESH:D002118', 'Chemical') :: ['calcium'] @entity1011 :: ('MESH:D003404', 'Chemical') :: ['creatinine']
@entity101 :: (MESH:D006973,Disease) :: ['hypertension']
